Navigation Links
AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
Date:9/28/2007

ses.

A total of 97 of 311 or 31% of patients had pathology-confirmed appendicitis in the study. AppyScore was able to correctly identify 95 of 97 patients with pathology-confirmed appendicitis. This exceptionally high sensitivity level of 98% for detecting the actual disease condition is considered statistically significant (95% CI = 93 to 99.9). Practically, this means a patient with a negative AppyScore has an extremely low likelihood of having appendicitis. This high sensitivity is a key hallmark for a successful screen test.

A large independent research report (Graff et al., 2000 Acad Emerg Med vol 7 n 11 pp 1244-55) of approximately 1,026 appendicitis patients from 12 hospitals across the Northeastern United States reported that an average of 18.6% of patients (ranging from a low of 10.6% to a high of 27.8%) were incorrectly diagnosed as not having appendicitis and were sent home, only to return to the emergency room with acute appendicitis in an advanced or burst condition. If the Graff report is representative of the state of the art for appendicitis diagnostics, then the 98% sensitivity of AppyScore in the company's study demonstrates the substantial impact this screen test could have for life threatening mis-diagnoses. The false negative diagnosis of appendicitis could become much less frequent using the AppyScore concept, resulting in fewer patients with appendicitis being erroneously sent home.

In the AspenBio study, there were a total of 109 appendectomies (appendix removal surgeries) of which only 97 had pathology-confirmed appendicitis, indicating there were 12 individuals or 11% who had a normal appendix removed. These 12 surgeries were classified as unnecessary on the basis of normal pathology findings. AppyScore would have successfully identified 7 of 12 (or 58%) of these unnecessary surgeries. In the US alone, an estimated 1-in-5 to 1-in-7 (14% to 20%) appendectomy surgeries remove a normal appendix due to an incorrect diagnosis.
'/>"/>

SOURCE AspenBio Pharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...KE,N.J.andNEWYORK,Nov.24/PRNewswire/-- EisaiInc.a...inistration(FDA)hasacceptedforreviewEisai,sNewDrug...pezilHClextendedrelease)tabletsforthetreatmentofmo...doseformulationcontains23mgofdonepezilHClinanexten...tallowsforgradualreleaseofthedrug.TheNDAisbasedona...
(Date:11/24/2009)...Calif.,Nov.24/PRNewswire-FirstCall/--ThoratecCorpo...chanicalcirculatorysupporttherapiestosave,supporta...ipatinginthe21stAnnualPiperJaffrayHealthCareConfer...ivevicepresidentandchieffinancialofficer,willprovi...StandardTime(5:30a.m.,PacificStandardTime). ,, ...
(Date:11/24/2009)...nn.,Nov.24/PRNewswire/--ZargisMedicalCorp.,asubsid...iemensCorporateResearch(NYSE: SI ),todayannouncedt...er24,2009episodeofCBS, TheEarlyShow duringasegment...ine,reviewedfivewinningproductsfromthepublication,...isawidely-viewedtelevisionmorningnewstalkshowbroad...
Breaking Medicine Technology:FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3Ganeden Biotech Racconto Introduce First Probiotic Pasta Line 55244 1Ganeden Biotech Racconto Introduce First Probiotic Pasta Line 55244 2Ganeden Biotech Racconto Introduce First Probiotic Pasta Line 55244 3Moszkito 28R 29 Expands its Archy 28TM 29 Footwear Collection to Include Closed Toed Shoes for Fall 2009 55242 1Moszkito 28R 29 Expands its Archy 28TM 29 Footwear Collection to Include Closed Toed Shoes for Fall 2009 55242 2Despite H1N1 Flu Threat Most Americans Havent Increased Hand Washing 55238 1Despite H1N1 Flu Threat Most Americans Havent Increased Hand Washing 55238 2
(Date:11/24/2009)...e accurate preliminary interpretation of emergency...g neuroradiologist unavailable, according to resul...center published in the December issue of the Jou...). , The accuracy of image interpretation is th...In most training programs, radiology residents pro...
(Date:11/24/2009)...swire/--EnigmaDiagnosticsLimited,thedecentraliseda...edtodayfourseniorappointmentsforitsUSandEuropeanof...identandCEOwithGregHamilton,ChiefOperatingOfficera...U.S.headquartersinSanDiego,California,theheadquart...edforassaydevelopment,R&Dandcommercialactiviti...
(Date:11/24/2009)...ewswire/--Parties,familydinners,andothergatherings...emerrimentcanchangetomiseryiffoodmakesyouorothersi...nh/20090824/FDALOGO ) ,, Typicalsymptomsoffoodb...s,whichcanstartanywherefromhourstodaysaftercontami...thatpracticingfourbasicfoodsafetymeasurescanhelppr...
(Date:11/24/2009)...PlusofMichiganhaslaunchedfournew HealthPlusSignatu...s18to64andtheirfamilieswhoarelookingtopurchaseaffo...lusSignature plansareavailableonlineat www.HealthP...althPlusservicearea.Moreinformation,includinghelpw...o1-877-562-0907. ,, "Wearepleasedtoofferanarray...
(Date:11/24/2009)...essants, benzodiazepines, review finds , ...o take antidepressants, sedatives and other psycho...lls, a new review shows. , Canadian researchers...al of 79,081 participants older than 60. The studi...ssure medicines; diuretics; beta blockers; sedativ...
Breaking Medicine News(10 mins):Health News:Enigma Diagnostics Expands Its US and European Executive Management Teams 2Health News:Enigma Diagnostics Expands Its US and European Executive Management Teams 3Health News:FDA Consumer Health Information: Food Safety Tips for Healthy Holidays 2Health News:HealthPlus Offers New Insurance Plans for Consumers Seeking Health Coverage on Their Own 2Health News:Some Prescription Meds May Raise Seniors' Risks of Falling 2
...more procedures to reopen arteries, study found , ... patients with blockages in the left main coronary..., often referred to as angioplasty -- may be a via...author of the study and director of interventional...
...-Joong Gan has established that patients with a hi...ht ventricle is not capable of pumping blood again...ds a longer rest phase between each pumping phase....the lungs (pulmonary hypertension), little attenti...
...oundation,s quick reaction to a recent attack by h...s of the need for Web security for some health,org...tion -- and those who,use its online forums for he...of epilepsy that causes people to,experience seizu...
... , Montreal, March 31, 2008 A team of Canadian ... responsible for a significant fraction of ALS (sp...s commonly referred to as Lou Gehrigs disease, an ...ine edition of Nature Genetics, the study on 200 h...
...arch 31, 2008 - Responding to a study published in...ded that lung transplants were harmful for childre...latest issue of Pediatric Transplantation refute t...he conclusions of the study on post-transplant sur...
...manufacturer,of the SurgiLance safety lancet, has ... Research Foundation (JDRF) to support ongoing res... celebration of the sale of its,500 millionth safe... SurgiLance safety lancets are used by them for,re...
Other Medicine News:Health News:Angioplasty Proves Reasonable Alternative to Bypass Surgery 2Health News:Epilepsy Foundation Takes Action Against Hackers 2Health News:Researchers identify a gene responsible for Lou Gehrig's disease 2Health News:Lung transplants not dangerous for children with cystic fibrosis, after all 2Health News:MediPurpose Supports Diabetes Research Effort 2
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
Medicine Products: